Marseille, March 16, 2015 - QIAGEN Marseille (Alternext - FR0010626028 - ALIPS) announces that its shareholders in extraordinary general meeting held today, voted in favor of the completion of the reorganization consisting of the contribution to HalioDx of all the assets and liabilities attached to its operational activities, with the exception of its intellectual property portfolio, research tax credit and cash assets.

Following this approval and in accordance with the Framework Agreement entered into on 6 February 2015 by QIAGEN Marseille, notably with HalioDxInvest and HalioDx (see press release dated 9 February 2015), the transaction was successfully completed in the form of a partial transfer of assets of the business contributed, followed by transfer of the securities received in consideration for the contribution.

The Board of Directors of QIAGEN Marseille has appointed Mr. Peer Schatz as CEO to replace Mr. Vincent Fert. Mr. Roland Sackers has also been appointed CFO.

Mr. Peer Schatz said: "We are pleased that the reorganization of QIAGEN Marseille has been successfully completed. This will optimize the commercialization of QIAGEN Marseille's intellectual property portfolio as part of the overall strategy of the QIAGEN group and allows the Marseille site and all of the jobs to be sustained within the realm of HalioDx. We congratulate the management team of QIAGEN Marseille, including Messrs. Vincent Fert and Stéphane Debono who carried through this project and convinced us of its merits for QIAGEN Marseille and its employees. The simplified public tender offer by QIAGEN NV filed on 11 March 2015 will also allow minority shareholders of QIAGEN Marseille to sell their shares under very favorable conditions."

Mr. Vincent Fert said: "After having spent 15 years developing Ipsogen, now known as QIAGEN Marseille since its successful integration within the QIAGEN group in 2012, I am particularly satisfied with the accomplishments of QIAGEN Marseille and happy to embark on a new journey, with the team that have placed their trust in me throughout the years, in the form of an ambitious entrepreneurial project by HalioDx."

Further information can be found at www.qiagenmarseille.com:
http://www.qiagenmarseille.com

QIAGEN Marseille: shareholders voted in favor of of the reorganization:
http://hugin.info/156032/R/1903937/677214.pdf


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: QIAGEN Marseille SA via Globenewswire
HUG#1903937